FCF Yield

A Free Cash Flow (FCF) Yield of 2.9% means that for every $100 you invest in Baxter's stock, the company generates about $2.90 in cash left over after covering operating expenses and capital investments.

This is below the healthcare sector median of 3.4%, placing Baxter in the 39th percentile among its peers. The metric has been decreasing over the last eight quarters, though the year-over-year change is not available; the most recent quarter-over-quarter change shows a +3.6% improvement to 2.9% from 2.8%. Despite that small sequential uptick, the longer-term downward trend suggests that Baxter's cash generation relative to its market value has been weakening. For an investor, the below-average yield combined with a declining trend indicates elevated risk, as the company may be struggling to convert its operations into shareholder cash. This directly supports the overall CAUTIOUS verdict: the low percentile rank and diminishing FCF Yield reinforce a watchful stance.

Frequently Asked Questions

Closest Sector Peers